March 6, 2018 | Israeli AI-based health startup Medial EarlySign announced that it raised $30 million in a recent funding round led by aMoon Fund, the investment arm of Check Point Software Technologies co-founder Marius Nacht. The company, founded in 2009, developed an algorithmic platform which uses blood results and other information from electronic health records to build clinical insights, helping health organizations with patient management. Horizon Ventures, based in Hong Kong, also participated in the funding round, as did Medial EarlySign co-founder and CTO Nir Kalkstein. Medial EarlySign CEO Ori Geva said the funding will be used to broaden the company’s solutions and expand clinical studies, Reuters reported. Last month, the company announced that it can predict which sufferers of diabetes will develop kidney dysfunction within a one-year time-frame using its predictive engines, or “Algomarkers.” The announcement came after the conclusion of a clinical data study based on Medial EarlySign’s tech which was able to identify at-risk patients by analyzing electronic health records including laboratory tests results, demographics, medication and diagnostic codes.